News
The FDA has approved Sol-Gel Technologies Ltd's (NASDAQ: SLGL) first proprietary drug product, Twyneo (tretinoin/benzoyl peroxide) cream, 0.1%/3%, indicated for acne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback